Monograph
S01AE07 - Moxifloxacin |
Not porphyrinogenic |
NP |
Side effects
Plasma concentrations are well below 1 µM (SPC) and hepatic exposure in therefore insignificant.
Rationale
Administered locally in the eye and systemic exposure is insignificant.
Chemical description
Fluoroquinolone antibiotic
Therapeutic characteristics
Moxifloxacin eye drops are used in the treatment of bacterial conjunctivitis.
Hepatic exposure
Moxifloxacin is metabolized mainly via sulfate or glucuronide conjugation, while the rest is excreted as the unchanged form. It is probably CYP450 independent (SPC).
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Summary of Product Characteristics | |
| 1. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Moxivig.
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Moxifloxacine · Vigamox 
Kanavig 
Abimox · Moxifloxacino · Moxifloxacino Farmaproject · Omnimoxa · Vigamox 
Moxifloxacina · Vigamox 
Moxifloxacin · Moxivig 
Vamocin · Vigamox · Xiflodrop 
Vigamox 
Flomixa · Floxamic · Monafox · Moxifloxacinum · Vigamox 
Kanavig 
Vigamox 
Vigamox 
Ekara · Lifodrox · Vigamox 
Elfonis
© NAPOS 2025